Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory effects of remimazolam during cardiopulmonary bypass and impact on pancreatic cancer
jRCT1031260169Recruiting
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in inflammation (2 arms), sponsored by none. Started Jun 2026; status: recruiting.
02
Drugs
remimazolam
03
Conditions
inflammation
Beyond the preview
Go deeper on jRCT1031260169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031260169.